High fetal splenic artery peak velocity in fetuses with hemoglobin Bart disease: A preliminary study

Objective. The purpose of this study was to evaluate the role of the splenic artery (SPA) peak systolic velocity (PSV) in identifying fetuses with hemoglobin (Hb) Bart disease among pregnancies at risk for the disease. Methods. Pregnancies at risk for fetal Hb Bart disease scheduled for cordocentesi...

Full description

Saved in:
Bibliographic Details
Main Authors: Tongsong T., Tongprasert F., Srisupundit K., Luewan S.
Format: Article
Language:English
Published: 2014
Online Access:http://www.scopus.com/inward/record.url?eid=2-s2.0-58149526704&partnerID=40&md5=23b34cd538afa3d396c8dc614ec8b7a3
http://www.ncbi.nlm.nih.gov/pubmed/19106351
http://cmuir.cmu.ac.th/handle/6653943832/2924
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English
id th-cmuir.6653943832-2924
record_format dspace
spelling th-cmuir.6653943832-29242014-08-30T02:25:33Z High fetal splenic artery peak velocity in fetuses with hemoglobin Bart disease: A preliminary study Tongsong T. Tongprasert F. Srisupundit K. Luewan S. Objective. The purpose of this study was to evaluate the role of the splenic artery (SPA) peak systolic velocity (PSV) in identifying fetuses with hemoglobin (Hb) Bart disease among pregnancies at risk for the disease. Methods. Pregnancies at risk for fetal Hb Bart disease scheduled for cordocentesis at 18 to 25 weeks' gestation at Maharaj Nakorn Chiang Mai Hospital were recruited into the study. The SPA PSV was measured before cordocentesis, and the final fetal diagnosis of Hb Bart disease was based on fetal Hb typing using high-performance liquid chromatography. Results. Seventy-six singleton pregnancies at risk for fetal Hb Bart disease were sonographically evaluated for the SPA PSV and underwent cordocentesis for fetal blood analysis. Among the 76 recruited pregnancies, 17 fetuses with Hb Bart disease were finally diagnosed by fetal blood analysis with high-performance liquid chromatography, and the remainder had no abnormalities or had the α-thalassemia 1 trait and were defined as unaffected fetuses. The mean SPA PSVs ± SD for the unaffected and affected fetuses were significantly different: 21.17 ± 3.7 cm/s (range, 13.8-29.9 cm/s) and 26.12 ± 3.6 cm/s (range, 20.4-31.5 cm/s) respectively. The SPA PSV of the affected fetuses was higher than that of the unaffected ones (Wilcoxon signed rank test, P < .001). Conclusions. Splenic artery PSV assessment at mid pregnancy may have a potential role in identifying fetuses with Hb Bart disease. Further studies to evaluate the effectiveness of the SPA PSV in differentiating affected from unaffected fetuses among pregnancies at risk are desirable. © 2009 by the American Institute of Ultrasound in Medicine. 2014-08-30T02:25:33Z 2014-08-30T02:25:33Z 2009 Article 02784297 19106351 JUMED http://www.scopus.com/inward/record.url?eid=2-s2.0-58149526704&partnerID=40&md5=23b34cd538afa3d396c8dc614ec8b7a3 http://www.ncbi.nlm.nih.gov/pubmed/19106351 http://cmuir.cmu.ac.th/handle/6653943832/2924 English
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
language English
description Objective. The purpose of this study was to evaluate the role of the splenic artery (SPA) peak systolic velocity (PSV) in identifying fetuses with hemoglobin (Hb) Bart disease among pregnancies at risk for the disease. Methods. Pregnancies at risk for fetal Hb Bart disease scheduled for cordocentesis at 18 to 25 weeks' gestation at Maharaj Nakorn Chiang Mai Hospital were recruited into the study. The SPA PSV was measured before cordocentesis, and the final fetal diagnosis of Hb Bart disease was based on fetal Hb typing using high-performance liquid chromatography. Results. Seventy-six singleton pregnancies at risk for fetal Hb Bart disease were sonographically evaluated for the SPA PSV and underwent cordocentesis for fetal blood analysis. Among the 76 recruited pregnancies, 17 fetuses with Hb Bart disease were finally diagnosed by fetal blood analysis with high-performance liquid chromatography, and the remainder had no abnormalities or had the α-thalassemia 1 trait and were defined as unaffected fetuses. The mean SPA PSVs ± SD for the unaffected and affected fetuses were significantly different: 21.17 ± 3.7 cm/s (range, 13.8-29.9 cm/s) and 26.12 ± 3.6 cm/s (range, 20.4-31.5 cm/s) respectively. The SPA PSV of the affected fetuses was higher than that of the unaffected ones (Wilcoxon signed rank test, P < .001). Conclusions. Splenic artery PSV assessment at mid pregnancy may have a potential role in identifying fetuses with Hb Bart disease. Further studies to evaluate the effectiveness of the SPA PSV in differentiating affected from unaffected fetuses among pregnancies at risk are desirable. © 2009 by the American Institute of Ultrasound in Medicine.
format Article
author Tongsong T.
Tongprasert F.
Srisupundit K.
Luewan S.
spellingShingle Tongsong T.
Tongprasert F.
Srisupundit K.
Luewan S.
High fetal splenic artery peak velocity in fetuses with hemoglobin Bart disease: A preliminary study
author_facet Tongsong T.
Tongprasert F.
Srisupundit K.
Luewan S.
author_sort Tongsong T.
title High fetal splenic artery peak velocity in fetuses with hemoglobin Bart disease: A preliminary study
title_short High fetal splenic artery peak velocity in fetuses with hemoglobin Bart disease: A preliminary study
title_full High fetal splenic artery peak velocity in fetuses with hemoglobin Bart disease: A preliminary study
title_fullStr High fetal splenic artery peak velocity in fetuses with hemoglobin Bart disease: A preliminary study
title_full_unstemmed High fetal splenic artery peak velocity in fetuses with hemoglobin Bart disease: A preliminary study
title_sort high fetal splenic artery peak velocity in fetuses with hemoglobin bart disease: a preliminary study
publishDate 2014
url http://www.scopus.com/inward/record.url?eid=2-s2.0-58149526704&partnerID=40&md5=23b34cd538afa3d396c8dc614ec8b7a3
http://www.ncbi.nlm.nih.gov/pubmed/19106351
http://cmuir.cmu.ac.th/handle/6653943832/2924
_version_ 1681419951233040384